Understanding Vitiligo | A Managed Healthcare Executive K-Cast

December 19, 2022

In this Managed Healthcare Executive® K-Cast, David Rosmarin, M.D., vice chair of education and research in the Department of Dermatology at Tufts Medical Center in Boston, discussed the economic burden, treatment goals, treatment options and health insurance issues related to vitiligo.

Express Scripts Adds Zorvye, Novel Psoriasis Treatment, to Formulary

November 21, 2022

Formulary placement is crucial to the commercial success of newly approved products, so Acrutis put out a press release last week announcing that Express Scripts had put Zoryve (roflumilast), the company's PDE4 inhibitor cream for plaque psoriasis, on its formulary.

Thyroid Abnormalities Rare Among Children with Vitiligo, Study Finds

September 26, 2022

The search for the causes of vitiligo continues. The findings in this study stand in contrast to another one conducted in eastern China that showed a high percentage of children with vitiligo had thyroid abnormalities.